CREMα expression in T cells from inflammatory bowel disease patients has not been investigated yet, further research will show if CREMα expression is elevated within T cells or inflamed tissues of these patients and if the CamKIV inhibitor KN-93 might also be of benefit in colitis. The gene discussed is CAMK4; the disease is colitis.